Activation of dendritic cells by local ablation of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International PublicationsWhole body hyperthermia in adjuvant therapy of children with renal cell carcinoma
/in Hypernephroma, International PublicationsNatural-killer cells and dendritic cells: „l’union fait la force“
/in Dendritic Cells, International PublicationsTowards therapeutic vaccines for colorectal carcinoma: a review of clinical trials
/in Colorectal Cancer, International PublicationsHsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine
/in Colorectal Cancer, International PublicationsClinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications[Study of Newcastle disease virus killing hepatocellular carcinoma cells in vitro]
/in International Publications, Newcastle Disease VirusVaccine therapy for non-Hodgkin’s lymphoma and other B-cell malignancies
/in International Publications, Malignant Lymphoma[Clinical effects of dendritic cells pulsed with autologous hepatoma cell lysates on the postoperative recurrence and metastasis of hepatocellular carcinoma]
/in Hepatocellular Carcinoma, International PublicationsIMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer